These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2135694)
1. Use of a specific monoclonal antibody to detect Mallory bodies in liver disease. Leevy CB; Sameshima Y; Yoshioka K; Leevy CM; Kanagasundaram N; Unoura M J Assoc Acad Minor Phys; 1990; 1(2):24-5, 28-30. PubMed ID: 2135694 [TBL] [Abstract][Full Text] [Related]
2. High molecular weight component of Mallory bodies detected by a monoclonal antibody. Zatloukal K; Denk H; Spurej G; Lackinger E; Preisegger KH; Franke WW Lab Invest; 1990 Apr; 62(4):427-34. PubMed ID: 1692099 [TBL] [Abstract][Full Text] [Related]
3. Ultrastructural, biochemical, and immunologic characterization of Mallory bodies in livers of griseofulvin-treated mice. Fimbriated rods of filaments containing prekeratin-like polypeptides. Franke WW; Denk H; Schmid E; Osborn M; Weber K Lab Invest; 1979 Feb; 40(2):207-20. PubMed ID: 219290 [TBL] [Abstract][Full Text] [Related]
4. Occurrence of immunohistochemically detected small Mallory bodies in liver disease. Yoshioka K; Kakumu S; Tahara H; Arao M; Fuji A; Hirofuji H; Hayashi T; Kano H Am J Gastroenterol; 1989 May; 84(5):535-9. PubMed ID: 2719010 [TBL] [Abstract][Full Text] [Related]
5. Relationship of Mallory bodies to the cytoskeleton of hepatocytes in griseofulvin-treated mice. Irie T; Benson NC; French SW Lab Invest; 1982 Oct; 47(4):336-45. PubMed ID: 6889660 [TBL] [Abstract][Full Text] [Related]
6. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes. Ohta M; Marceau N; Perry G; Manetto V; Gambetti P; Autilio-Gambetti L; Metuzals J; Kawahara H; Cadrin M; French SW Lab Invest; 1988 Dec; 59(6):848-56. PubMed ID: 2462130 [TBL] [Abstract][Full Text] [Related]
7. High molecular weight components are main constituents of Mallory bodies isolated with a fluorescence activated cell sorter. Zatloukal K; Böck G; Rainer I; Denk H; Weber K Lab Invest; 1991 Feb; 64(2):200-6. PubMed ID: 1705301 [TBL] [Abstract][Full Text] [Related]
8. Change of cytokeratin organization during development of Mallory bodies as revealed by a monoclonal antibody. Hazan R; Denk H; Franke WW; Lackinger E; Schiller DL Lab Invest; 1986 May; 54(5):543-53. PubMed ID: 2422438 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of mallory body formation induced by okadaic acid in drug-primed mice. Yuan QX; Nagao Y; Gaal K; Hu B; French SW Exp Mol Pathol; 1998 Oct; 65(2):87-103. PubMed ID: 9828150 [TBL] [Abstract][Full Text] [Related]
11. Experimental Mallory body formation is accompanied by modulation of the expression of multidrug-resistance genes and their products. Preisegger KH; Stumptner C; Riegelnegg D; Brown PC; Silverman JA; Thorgeirsson SS; Denk H Hepatology; 1996 Jul; 24(1):248-52. PubMed ID: 8707270 [TBL] [Abstract][Full Text] [Related]
12. Electron microscopic study of the in vitro calcium-dependent degradation of Mallory bodies and intermediate filaments in hepatocytes. Irie T; Benson NC; French SW Lab Invest; 1984 Mar; 50(3):303-12. PubMed ID: 6199585 [TBL] [Abstract][Full Text] [Related]
13. Rearrangement of the hepatocyte cytoskeleton after toxic damage: involution, dispersal and peripheral accumulation of Mallory body material after drug withdrawal. Denk H; Franke WW Eur J Cell Biol; 1981 Feb; 23(2):241-9. PubMed ID: 7193580 [TBL] [Abstract][Full Text] [Related]
14. Dexamethasone enhances mallory body formation in drug-primed mouse liver. Yuan QX; Nagao Y; French BA; Wan YJ; French SW Exp Mol Pathol; 2000 Dec; 69(3):202-10. PubMed ID: 11115361 [TBL] [Abstract][Full Text] [Related]
15. Is apoptosis involved in alcoholic hepatitis? Kawahara H; Matsuda Y; Takase S Alcohol Alcohol Suppl; 1994; 29(1):113-8. PubMed ID: 9063809 [TBL] [Abstract][Full Text] [Related]
16. Expression of a mutant ER-retained polytope membrane protein in cultured rat hepatocytes results in Mallory body formation. Hirano K; Roth J; Zuber C; Ziak M Histochem Cell Biol; 2002 Jan; 117(1):41-53. PubMed ID: 11819096 [TBL] [Abstract][Full Text] [Related]
17. Changes in the cytokeratin intermediate filament cytoskeleton associated with Mallory body formation in mouse and human liver. Katsuma Y; Swierenga SH; Khettry U; Marceau N; French SW Hepatology; 1987; 7(6):1215-23. PubMed ID: 2445643 [TBL] [Abstract][Full Text] [Related]
18. Infiltrating polymorphonuclear leukocytes and apoptotic bodies derived from hepatocytes but not from ballooning hepatocytes containing Mallory bodies show nuclear DNA fragmentation in alcoholic hepatitis. Takahashi T; So-Wan T; Kamimura T; Asakura H Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):68S-73S. PubMed ID: 10803784 [TBL] [Abstract][Full Text] [Related]
19. Ubiquitin: an immunohistochemical marker of Mallory bodies and alcoholic liver disease. Vyberg M; Leth P APMIS Suppl; 1991; 23():46-52. PubMed ID: 1652996 [TBL] [Abstract][Full Text] [Related]
20. Modifications in cytokeratin and actin in cultured liver cells derived from griseofulvin-fed mice. Cadrin M; Anderson NM; Aasheim LH; Kawahara H; Franks DJ; French SW Lab Invest; 1995 Apr; 72(4):453-60. PubMed ID: 7536860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]